BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230630T120000
DTEND;TZID=America/Toronto:20230630T130000
DTSTAMP:20260628T081048
CREATED:20220902T211051Z
LAST-MODIFIED:20230626T144431Z
UID:10000016-1688126400-1688130000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG - The Leading Strand Series June 2023
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nClick HERE to register. \nCCMG Position Statement: Genetic And Metabolic Investigations For Patients With Neurodevelopmental Disorders \nThe co-chairs of the CCMG working group to develop a guideline for genetic and metabolic investigations for patients with NDDs will discuss the process and results. A national multidisciplinary working group developed a position statement for the genetic and metabolic investigation of patients with neurodevelopmental disorders (NDDs). The impetus for this guideline\, the methodology and process for its development and key recommendations will be presented. \nLearning Objectives: \n\nUnderstand the impetus for a Canadian guideline for genetic and metabolic investigation of neurodevelopmental disorders (NDDs)\nDescribe and apply methodologies for guideline development\nPlan an investigation for patients with neurodevelopmental disorders\n\nSpeakers \nDr. Melissa Carter\nDr. Hilary Vallance \nBios \n \n  \nDr. Melissa Carter is a clinical geneticist at CHEO in Ottawa\, specializing in neurodevelopmental disorders. She completed her residency in Ottawa and then a fellowship in developmental pediatrics in Toronto. She is the co-chair of a CCMG working group to develop guidelines for etiological investigations for patients with neurodevelopmental disorders\, and is currently the Clinical Lead of the Neurodevelopmental Genetics expert group at Ontario Health. \n  \n \n  \nDr. Hilary Vallance is a Medical Biochemist / Biochemical Geneticist at BC Children’s Hospital who obtained her MD from the University of British Columbia (UBC). She completed a residency in Medical Biochemistry at UBC followed by fellowship training in Biochemical Genetics. She is the Director of the BC Newborn Screening Program. Her research contributions have been in the area of inborn errors of metabolism and newborn screening for treatable conditions. \n  \nDates \nSeptember 23\nOctober 28\nNovember 25\nDecember 16\nJanuary 27\nFebruary 24\nMarch 31\nApril 28\nMay 26\nJune 30 \nClick HERE to register.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-june-2023/
CATEGORIES:Leading Strand
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
END:VCALENDAR